These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 32790406)
1. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV? Nguyen HL; Lan PD; Thai NQ; Nissley DA; O'Brien EP; Li MS J Phys Chem B; 2020 Aug; 124(34):7336-7347. PubMed ID: 32790406 [TBL] [Abstract][Full Text] [Related]
2. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Lan J; Ge J; Yu J; Shan S; Zhou H; Fan S; Zhang Q; Shi X; Wang Q; Zhang L; Wang X Nature; 2020 May; 581(7807):215-220. PubMed ID: 32225176 [TBL] [Abstract][Full Text] [Related]
3. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2. Corrêa Giron C; Laaksonen A; Barroso da Silva FL Virus Res; 2020 Aug; 285():198021. PubMed ID: 32416259 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of receptor recognition by SARS-CoV-2. Shang J; Ye G; Shi K; Wan Y; Luo C; Aihara H; Geng Q; Auerbach A; Li F Nature; 2020 May; 581(7807):221-224. PubMed ID: 32225175 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
6. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes. Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095 [TBL] [Abstract][Full Text] [Related]
7. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Behloul N; Baha S; Shi R; Meng J Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235 [TBL] [Abstract][Full Text] [Related]
8. The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor. Brielle ES; Schneidman-Duhovny D; Linial M Viruses; 2020 Apr; 12(5):. PubMed ID: 32365751 [TBL] [Abstract][Full Text] [Related]
9. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals. Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279 [TBL] [Abstract][Full Text] [Related]
10. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Ali A; Vijayan R Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162 [TBL] [Abstract][Full Text] [Related]
12. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
13. Critical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV. Bai C; Warshel A J Phys Chem B; 2020 Jul; 124(28):5907-5912. PubMed ID: 32551652 [TBL] [Abstract][Full Text] [Related]
14. Cell entry mechanisms of SARS-CoV-2. Shang J; Wan Y; Luo C; Ye G; Geng Q; Auerbach A; Li F Proc Natl Acad Sci U S A; 2020 May; 117(21):11727-11734. PubMed ID: 32376634 [TBL] [Abstract][Full Text] [Related]
15. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847 [TBL] [Abstract][Full Text] [Related]
16. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
17. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2. Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of receptor interactions between SARS-CoV and SARS-CoV-2 from molecular modeling. Lai HTT; Nguyen LH; Phan AD; Kranjc A; Nguyen TT; Nguyen-Manh D J Mol Model; 2022 Sep; 28(10):305. PubMed ID: 36074206 [TBL] [Abstract][Full Text] [Related]
19. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants. Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849 [TBL] [Abstract][Full Text] [Related]
20. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor. Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]